[Effect of cyclazenine on the accumulation and release of sympathomimetic amines in the heart].
D000818:Animals; D003864:Depression, Chemical; D004837:Epinephrine / Q000032:analysis; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D008750:Methyldopa / Q000494:pharmacology; D009206:Myocardium / Q000032:analysis / Q000378:metabolism*; D009638:Norepinephrine / Q000032:analysis; D009647:Normetanephrine / Q000096:biosynthesis; D010879:Piperazines / Q000037:antagonists & inhibitors; D011725:Pyridines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013566:Sympathomimetics / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014439:Tyramine / Q000037:antagonists & inhibitors
D010879:Piperazines; D011725:Pyridines; D013566:Sympathomimetics; D009647:Normetanephrine; D008750:Methyldopa; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine
Die Wirkung von Cyclazenin auf die Speicherung und Freisetzung sympathicomimetischer Amine im Herzen.